ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Geriatric Medicine

Top Geriatric Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HAROLD WAGNER D.O.

Geriatric Medicine

277

$14.8K

69
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

59%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $64

YAW FRIMPONG-BADU MD

Geriatric Medicine

605

$19.5K

74
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

39%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 27%

$32
Average prescription price

Avg: $64

MELCHOR ACOSTA MD

Geriatric Medicine

24,697

$1.41M

522
459 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

33%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $64

CHARLES MAXVILL DO

Geriatric Medicine

56,911

$3.64M

1085
900 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

38%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $64

FOLASADE OJO MD

Geriatric Medicine

26,715

$1.73M

514
416 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

26%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$65
Average prescription price

Avg: $64

JOSE ROSADO MORALES MD

Geriatric Medicine

11,169

$623K

385
314 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

32%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $64

REZIUDDIN SIDDIQUE M. D.

Geriatric Medicine

43,748

$2.66M

1039
860 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

33%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $64

KHOREN HEKIMIAN DO

Geriatric Medicine

67,122

$4.67M

1287
946 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

35%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $64

OMAR ZANTUA M.D.

Geriatric Medicine

25,352

$2M

469
419 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

25%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 27%

$79
Average prescription price

Avg: $64

ILIANA AMAYA GREVER M.D.

Geriatric Medicine

1,516

$72K

245
209 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

31%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$47
Average prescription price

Avg: $64

STEPHANIE MC CLURE MD

Geriatric Medicine

1,433

$100K

133
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

38%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $64

ANIL GARYALI M.D.

Geriatric Medicine

17,509

$1.05M

272
236 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

28%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $64

KENT DAVIS MD

Geriatric Medicine

33,573

$1.93M

895
777 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

32%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $64

RICHARD STRICKLAND M.D.

Geriatric Medicine

10,458

$558K

280
264 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

31%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $64

JIBRAIL KASPERKHAN M.D.

Geriatric Medicine

44,085

$3.03M

760
682 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

30%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $64

GEOFFREY WILLIAMS MD

Geriatric Medicine

2,499

$196K

47
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

30%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$79
Average prescription price

Avg: $64

JANET LIETO DO

Geriatric Medicine

937

$34.1K

40
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

28%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 27%

$36
Average prescription price

Avg: $64

SURAINDER AJMANI M.D.

Geriatric Medicine

10,840

$734K

320
220 are 65+

13%
patients receiving schedule two controlled substances

Avg: 2%

24%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$68
Average prescription price

Avg: $64

GEORGE CANTU MD

Geriatric Medicine

6,357

$442K

260
215 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

31%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $64

VINOD KAUSHIK M.D.

Geriatric Medicine

8,027

$421K

338
331 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

28%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $64

COLLEEN KENNEDY M.D.

Geriatric Medicine

2,848

$207K

103
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

27%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $64

PEGGY RUSSELL D.O.

Geriatric Medicine

12,363

$680K

429
391 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

25%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $64

NEETA NAYAK MD

Geriatric Medicine

29,948

$1.75M

739
611 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

30%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $64

ALICE AJIM MD

Geriatric Medicine

6,678

$328K

492
310 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

23%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$49
Average prescription price

Avg: $64

SOROUSH BEHNAM MD

Geriatric Medicine

24,918

$1.39M

733
686 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $64

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank